Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications (CROSBI ID 315335)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Talapko, Jasminka ; Meštrović, Tomislav ; Juzbašić, Martina ; Tomas, Matej ; Erić, Suzana ; Horvat Aleksijević, Lorena ; Bekić, Sanja ; Schwarz, Dragan ; Matić, Suzana ; Neuberg, Marijana et al. Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications // Antibiotics, 11 (2022), 10; 1417, 17. doi: 10.3390/antibiotics11101417

Podaci o odgovornosti

Talapko, Jasminka ; Meštrović, Tomislav ; Juzbašić, Martina ; Tomas, Matej ; Erić, Suzana ; Horvat Aleksijević, Lorena ; Bekić, Sanja ; Schwarz, Dragan ; Matić, Suzana ; Neuberg, Marijana ; Škrlec, Ivana

engleski

Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications

Abstract: The growing emergence of antimicrobial resistance represents a global problem that not only influences healthcare systems but also has grave implications for political and economic processes. As the discovery of novel antimicrobial agents is lagging, one of the solutions is innovative therapeutic options that would expand our armamentarium against this hazard. Compounds of interest in many such studies are antimicrobial peptides (AMPs), which actually represent the host’s first line of defense against pathogens and are involved in innate immunity. They have a broad range of antimicrobial activity against Gram- negative and Gram-positive bacteria, fungi, and viruses, with specific mechanisms of action utilized by different AMPs. Coupled with a lower propensity for resistance development, it is becoming clear that AMPs can be seen as emerging and very promising candidates for more pervasive usage in the treatment of infectious diseases. However, their use in quotidian clinical practice is not without challenges. In this review, we aimed to summarize state-of-the-art evidence on the structure and mechanisms of action of AMPs, as well as to provide detailed information on their antimicrobial activity. We also aimed to present contemporary evidence of clinical trials and application of AMPs and highlight their use beyond infectious diseases and potential challenges that may arise with their increasing availability.

antimicrobial peptides ; antimicrobial resistance ; antimicrobial effects ; antibacterial activity ; antiviral activity ; antifungal activity ; microorganisms ; clinical trials ; infections ; treatment

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

11 (10)

2022.

1417

17

objavljeno

2079-6382

10.3390/antibiotics11101417

Povezanost rada

Biologija, Dentalna medicina, Kliničke medicinske znanosti, Temeljne medicinske znanosti

Poveznice
Indeksiranost